A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol.

Yi ZengAnna-Barbara MoscickiVikrant V SahasrabuddheFrancisco GarciaHeide WooChiu-Hsieh HsuEva SzaboEileen DimondSusan VanzziniAngelica MondragonValerie ButlerHillary DeRoseH-H Sherry Chow

Published in: BMC cancer (2019)

ClinicalTrials.gov Identifier: NCT02568566 . Registered on October 6, 2015.

Keyphrases

open label
phase iii
phase ii
clinical trial
study protocol
double blind
randomized controlled trial
phase ii study
placebo controlled
high grade
radiation therapy
rectal cancer